As a result, we conducted a thorough investigation on the predictive impact of BET family members in ovarian cancer patients, in addition to their relationships with clinical stages, pathological grades, and TP53 subtypes along with applied chemotherapy. The gene discussed is DNER; the disease is ovarian carcinoma.